Early growth response transcription factor (EGR1) has been subject to reports linked to its negative role in cardiovascular disease progression (Khachigian, 2021), profibrotic response, and physiologic and pathological connective tissue remodeling (Bhattacharyya et al., 2011). This evidence concerns the gene EGR1 and cardiovascular disorder.